Westport · Series C–Late Stage · 7 people tracked
Investment thesis
HighCape Capital is a growth equity fund focused exclusively on innovative Life Sciences companies, helping them transition from early business stages into thriving organizations. The firm invests across connected health, medical devices and tools, and biotechnology. Its team of experienced operators brings backgrounds in founding, financing, leading, growing, and exiting life sciences companies across multiple industry segments. HighCape adds value by leveraging its operational and scientific experience, working collaboratively with portfolio companies, and supporting entrepreneurship.
Source: firm website, verified Aug 18, 2026.
Team · 7 people
from the firm's website & public directoriesWhat they invest in
from 6 of 12 portfolio companiesBiotech ×5Healthtech ×3Medical Devices ×3Digital Health ×1Hardware ×1Wellness & Fitness ×1
HQs:United States×3
Investments · 12 tracked
founders shown can be your intro pathDevelops therapeutics targeting altered NAD metabolism in cancer, based on IP licensed from Yale University.
Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.
BiotechNew Haven, US
Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Kevin L. Rakin(Executive Officer, Director)Stanley Choy(Executive Officer)Ranjit Bindra(Director)
BoardColleen Cuffaro(Director)in
Co-investorsCanaan PartnersConnecticut InnovationsOUP (Osage University Partners)
Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.
Oncology-focused platform company whose alphalex technology enables antigen-independent targeted intracellular delivery of small molecule cancer drugs; based in New Haven, CT.
Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery.
BiotechHealthtechMedical Devices
Per Hellsund(Co-founder, President & CEO)Ranjit Bindra(Scientific Co-founder & Chief Scientific Advisor)Peter Glazer(Scientific Co-founder & Chief Medical Advisor)
Co-investorsConnecticut Innovations
Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction.
BiotechHealthtechMedical Devices
C. Randal Mills(Founder, President & CEO)
BiotechNew Haven, US
Ranjit Bindra(Director)Kingson Lin(Cofounder)Kevin L. Rakin(Executive Officer, Director)
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsPathway Bioventures
Quantum-Si develops benchtop instruments (Platinum and Platinum Pro) for single-molecule, single-amino-acid resolution protein sequencing, used to identify proteins, protein variants, and post-translational modifications.
BiotechHardwareMedical Devices
Wellinks offers a virtual COPD management program that connects members with respiratory therapists and clinical coaches for coaching, education, and remote monitoring via an app with a pulse oximeter and spirometer.
Digital HealthHealthtechWellness & Fitness
Co-investorsConnecticut Innovations
Innovator in non-invasive surgical skin closure devices used in over 100,000 cases across 30+ countries; headquartered in Campbell, CA.
Portfolio news
latest coverage across their companiesWellinks · wellinks.com · Aug 18, 2025
Frequently asked questions
- How many investments has HighCape Capital made?
- HighCape Capital has 12 tracked investments.
- What stage does HighCape Capital invest at?
- HighCape Capital invests at the Series C, Growth, Late Stage stages.
- What sectors does HighCape Capital focus on?
- HighCape Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is HighCape Capital located?
- HighCape Capital is headquartered in Westport, US.
- Who does HighCape Capital co-invest with?
- HighCape Capital most often shares deals with Connecticut Innovations, Canaan Partners, OrbiMed, among 5 tracked co-investors.
Similar investors
Sofinnova is an investment firm that partners with biotech companies from inception through growth, supporting drug development, the regulatory process, company building, and IPO.
HM Venture Partners is a healthcare venture capital firm backing high-growth biotech and medtech companies worldwide across all stages, with three funds under management.
Panacea Venture is a global investment firm, spun out from Kleiner Perkins, focused on life sciences and healthcare innovation. It invests across geographies and stages, from company formation through expansion and public markets.
Olive Tree Capital invests in technology and life sciences companies, backing entrepreneurs across healthcare, fintech, enterprise, AI/ML, and frontier technology sectors.
Pivotal Life Sciences is an investment platform focused on funding innovative companies developing therapeutic products and technologies aimed at major unmet medical needs.